APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mefenamic Acid

Compare research editions
View pricing & licenses

Selected research

Industry Research

Mefenamic Acid Industry Research Report 2026

Report ID 174011610519 December 2025147 pages

Choose your research edition.

Industry ResearchMefenamic Acid Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Mefenamic Acid Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Mefenamic Acid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mefenamic Acid Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Mefenamic Acid Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Mefenamic Acid market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Mefenamic Acid is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Mefenamic Acid is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Mefenamic Acid is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Mefenamic Acid include AA Pharma, ABL Lifecare, Adelco, Agron Remedies, Apotex, Captab, Chemidex Pharma, Daiichi Sankyo and EMS Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Mefenamic Acid market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Mefenamic Acid Market by Company

AA Pharma

ABL Lifecare

Adelco

Agron Remedies

Apotex

Captab

Chemidex Pharma

Daiichi Sankyo

EMS Pharma

Esteve

Farmo Quimica

IASIS Pharmaceuticals Hellas

Koa Isei

Mankind

Nisshin Pharmaceutical

Sanofi Aventis

Shinto Organics

Shionogi Pharma

Solitaire Pharmacia

Streuli Pharma,

Wockhardt

Yung Sine

Pfizer

Teva

Mefenamic Acid Segment by Type

Patent

Generic

Mefenamic Acid Segment by Application

On-line

Drug Store

Hospital

Mefenamic Acid Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mefenamic Acid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mefenamic Acid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mefenamic Acid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Mefenamic Acid manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Mefenamic Acid by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Mefenamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mefenamic Acid Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Mefenamic Acid Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Mefenamic Acid Sales Market Share by Manufacturers (2021-2026) Table 8. Global Mefenamic Acid Revenue of Manufacturers (2021-2026) Table 9. Global Mefenamic Acid Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Mefenamic Acid Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Mefenamic Acid Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Mefenamic Acid, Product Type & Application Table 14. Global Mefenamic Acid Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Mefenamic Acid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AA Pharma Company Information Table 19. AA Pharma Business Overview Table 20. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. AA Pharma Mefenamic Acid Product Portfolio Table 22. AA Pharma Recent Developments Table 23. ABL Lifecare Company Information Table 24. ABL Lifecare Business Overview Table 25. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. ABL Lifecare Mefenamic Acid Product Portfolio Table 27. ABL Lifecare Recent Developments Table 28. Adelco Company Information Table 29. Adelco Business Overview Table 30. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Adelco Mefenamic Acid Product Portfolio Table 32. Adelco Recent Developments Table 33. Agron Remedies Company Information Table 34. Agron Remedies Business Overview Table 35. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Agron Remedies Mefenamic Acid Product Portfolio Table 37. Agron Remedies Recent Developments Table 38. Apotex Company Information Table 39. Apotex Business Overview Table 40. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Apotex Mefenamic Acid Product Portfolio Table 42. Apotex Recent Developments Table 43. Captab Company Information Table 44. Captab Business Overview Table 45. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Captab Mefenamic Acid Product Portfolio Table 47. Captab Recent Developments Table 48. Chemidex Pharma Company Information Table 49. Chemidex Pharma Business Overview Table 50. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Chemidex Pharma Mefenamic Acid Product Portfolio Table 52. Chemidex Pharma Recent Developments Table 53. Daiichi Sankyo Company Information Table 54. Daiichi Sankyo Business Overview Table 55. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Daiichi Sankyo Mefenamic Acid Product Portfolio Table 57. Daiichi Sankyo Recent Developments Table 58. EMS Pharma Company Information Table 59. EMS Pharma Business Overview Table 60. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. EMS Pharma Mefenamic Acid Product Portfolio Table 62. EMS Pharma Recent Developments Table 63. Esteve Company Information Table 64. Esteve Business Overview Table 65. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Esteve Mefenamic Acid Product Portfolio Table 67. Esteve Recent Developments Table 68. Farmo Quimica Company Information Table 69. Farmo Quimica Business Overview Table 70. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Farmo Quimica Mefenamic Acid Product Portfolio Table 72. Farmo Quimica Recent Developments Table 73. IASIS Pharmaceuticals Hellas Company Information Table 74. IASIS Pharmaceuticals Hellas Business Overview Table 75. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio Table 77. IASIS Pharmaceuticals Hellas Recent Developments Table 78. Koa Isei Company Information Table 79. Koa Isei Business Overview Table 80. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Koa Isei Mefenamic Acid Product Portfolio Table 82. Koa Isei Recent Developments Table 83. Mankind Company Information Table 84. Mankind Business Overview Table 85. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mankind Mefenamic Acid Product Portfolio Table 87. Mankind Recent Developments Table 88. Nisshin Pharmaceutical Company Information Table 89. Nisshin Pharmaceutical Business Overview Table 90. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Nisshin Pharmaceutical Mefenamic Acid Product Portfolio Table 92. Nisshin Pharmaceutical Recent Developments Table 93. Sanofi Aventis Company Information Table 94. Sanofi Aventis Business Overview Table 95. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sanofi Aventis Mefenamic Acid Product Portfolio Table 97. Sanofi Aventis Recent Developments Table 98. Shinto Organics Company Information Table 99. Shinto Organics Business Overview Table 100. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Shinto Organics Mefenamic Acid Product Portfolio Table 102. Shinto Organics Recent Developments Table 103. Shionogi Pharma Company Information Table 104. Shionogi Pharma Business Overview Table 105. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shionogi Pharma Mefenamic Acid Product Portfolio Table 107. Shionogi Pharma Recent Developments Table 108. Solitaire Pharmacia Company Information Table 109. Solitaire Pharmacia Business Overview Table 110. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Solitaire Pharmacia Mefenamic Acid Product Portfolio Table 112. Solitaire Pharmacia Recent Developments Table 113. Streuli Pharma, Company Information Table 114. Streuli Pharma, Business Overview Table 115. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Streuli Pharma, Mefenamic Acid Product Portfolio Table 117. Streuli Pharma, Recent Developments Table 118. Wockhardt Company Information Table 119. Wockhardt Business Overview Table 120. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Wockhardt Mefenamic Acid Product Portfolio Table 122. Wockhardt Recent Developments Table 123. Yung Sine Company Information Table 124. Yung Sine Business Overview Table 125. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Yung Sine Mefenamic Acid Product Portfolio Table 127. Yung Sine Recent Developments Table 128. Pfizer Company Information Table 129. Pfizer Business Overview Table 130. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Pfizer Mefenamic Acid Product Portfolio Table 132. Pfizer Recent Developments Table 133. Teva Company Information Table 134. Teva Business Overview Table 135. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Teva Mefenamic Acid Product Portfolio Table 137. Teva Recent Developments Table 138. Global Mefenamic Acid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 139. Global Mefenamic Acid Sales by Region (2021-2026) & (K Units) Table 140. Global Mefenamic Acid Sales Market Share by Region (2021-2026) Table 141. Global Mefenamic Acid Sales by Region (2027-2032) & (K Units) Table 142. Global Mefenamic Acid Sales Market Share by Region (2027-2032) Table 143. Global Mefenamic Acid Revenue by Region (2021-2026) & (US$ Million) Table 144. Global Mefenamic Acid Revenue Market Share by Region (2021-2026) Table 145. Global Mefenamic Acid Revenue by Region (2027-2032) & (US$ Million) Table 146. Global Mefenamic Acid Revenue Market Share by Region (2027-2032) Table 147. North America Mefenamic Acid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. North America Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 149. North America Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 150. North America Mefenamic Acid Revenue by Country (2021-2026) & (US$ Million) Table 151. North America Mefenamic Acid Revenue by Country (2027-2032) & (US$ Million) Table 152. Europe Mefenamic Acid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Europe Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 154. Europe Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 155. Europe Mefenamic Acid Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Mefenamic Acid Revenue by Country (2027-2032) & (US$ Million) Table 157. Asia Pacific Mefenamic Acid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Asia Pacific Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 159. Asia Pacific Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 160. Asia Pacific Mefenamic Acid Revenue by Country (2021-2026) & (US$ Million) Table 161. Asia Pacific Mefenamic Acid Revenue by Country (2027-2032) & (US$ Million) Table 162. South America Mefenamic Acid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. South America Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 164. South America Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 165. South America Mefenamic Acid Revenue by Country (2021-2026) & (US$ Million) Table 166. South America Mefenamic Acid Revenue by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Mefenamic Acid Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 168. Middle East and Africa Mefenamic Acid Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Mefenamic Acid Sales by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Mefenamic Acid Revenue by Country (2021-2026) & (US$ Million) Table 171. Middle East and Africa Mefenamic Acid Revenue by Country (2027-2032) & (US$ Million) Table 172. Global Mefenamic Acid Sales by Type (2021-2026) & (K Units) Table 173. Global Mefenamic Acid Sales by Type (2027-2032) & (K Units) Table 174. Global Mefenamic Acid Sales Market Share by Type (2021-2026) Table 175. Global Mefenamic Acid Sales Market Share by Type (2027-2032) Table 176. Global Mefenamic Acid Revenue by Type (2021-2026) & (US$ Million) Table 177. Global Mefenamic Acid Revenue by Type (2027-2032) & (US$ Million) Table 178. Global Mefenamic Acid Revenue Market Share by Type (2021-2026) Table 179. Global Mefenamic Acid Revenue Market Share by Type (2027-2032) Table 180. Global Mefenamic Acid Price by Type (2021-2026) & (US$/Unit) Table 181. Global Mefenamic Acid Price by Type (2027-2032) & (US$/Unit) Table 182. Global Mefenamic Acid Sales by Application (2021-2026) & (K Units) Table 183. Global Mefenamic Acid Sales by Application (2027-2032) & (K Units) Table 184. Global Mefenamic Acid Sales Market Share by Application (2021-2026) Table 185. Global Mefenamic Acid Sales Market Share by Application (2027-2032) Table 186. Global Mefenamic Acid Revenue by Application (2021-2026) & (US$ Million) Table 187. Global Mefenamic Acid Revenue by Application (2027-2032) & (US$ Million) Table 188. Global Mefenamic Acid Revenue Market Share by Application (2021-2026) Table 189. Global Mefenamic Acid Revenue Market Share by Application (2027-2032) Table 190. Global Mefenamic Acid Price by Application (2021-2026) & (US$/Unit) Table 191. Global Mefenamic Acid Price by Application (2027-2032) & (US$/Unit) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Mefenamic Acid Distributors List Table 195. Mefenamic Acid Customers List Table 196. Mefenamic Acid Industry Trends Table 197. Mefenamic Acid Industry Drivers Table 198. Mefenamic Acid Industry Restraints Table 199. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Mefenamic Acid Product Image Figure 5. Global Mefenamic Acid Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Mefenamic Acid Market Size (2021-2032) & (US$ Million) Figure 7. Global Mefenamic Acid Sales (2021-2032) & (K Units) Figure 8. Global Mefenamic Acid Average Price (US$/Unit) & (2021-2032) Figure 9. Patent Product Image Figure 10. Generic Product Image Figure 11. On-line Product Image Figure 12. Drug Store Product Image Figure 13. Hospital Product Image Figure 14. Global Mefenamic Acid Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Mefenamic Acid Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Mefenamic Acid Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Mefenamic Acid Sales by Region in 2025 Figure 20. Global Mefenamic Acid Revenue by Region in 2025 Figure 21. North America Mefenamic Acid Market Size by Country in 2025 Figure 22. North America Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 23. North America Mefenamic Acid Revenue Market Share by Country (2021-2032) Figure 24. United States Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Mefenamic Acid Market Size by Country in 2025 Figure 27. Europe Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 28. Europe Mefenamic Acid Revenue Market Share by Country (2021-2032) Figure 29. Germany Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Netherlands Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Asia Pacific Mefenamic Acid Market Size by Country in 2025 Figure 35. Asia Pacific Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 36. Asia Pacific Mefenamic Acid Revenue Market Share by Country (2021-2032) Figure 37. China Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Japan Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. South Korea Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. India Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Australia Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. China Taiwan Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South America Mefenamic Acid Market Size by Country in 2025 Figure 46. South America Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 47. South America Mefenamic Acid Revenue Market Share by Country (2021-2032) Figure 48. Mexico Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Brazil Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Argentina Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Middle East and Africa Mefenamic Acid Market Size by Country in 2025 Figure 52. Middle East and Africa Mefenamic Acid Sales Market Share by Country (2021-2032) Figure 53. Middle East and Africa Mefenamic Acid Revenue Market Share by Country (2021-2032) Figure 54. Turkey Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Saudi Arabia Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. UAE Mefenamic Acid Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Global Mefenamic Acid Sales Market Share by Type (2021-2032) Figure 58. Global Mefenamic Acid Revenue Market Share by Type (2021-2032) Figure 59. Global Mefenamic Acid Price (US$/Unit) by Type (2021-2032) Figure 60. Global Mefenamic Acid Sales Market Share by Application (2021-2032) Figure 61. Global Mefenamic Acid Revenue Market Share by Application (2021-2032) Figure 62. Global Mefenamic Acid Price (US$/Unit) by Application (2021-2032) Figure 63. Mefenamic Acid Value Chain Figure 64. Mefenamic Acid Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Mefenamic Acid Industry Opportunities and Challenges

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • On-line
  • Drug Store
  • Hospital
Companies covered
  • AA Pharma
  • ABL Lifecare
  • Adelco
  • Agron Remedies
  • Apotex
  • Captab
  • Chemidex Pharma
  • Daiichi Sankyo
  • EMS Pharma
  • Esteve
  • Farmo Quimica
  • IASIS Pharmaceuticals Hellas
  • Koa Isei
  • Mankind
  • Nisshin Pharmaceutical
  • Sanofi Aventis
  • Shinto Organics
  • Shionogi Pharma
  • Solitaire Pharmacia
  • Streuli Pharma,
  • Wockhardt
  • Yung Sine
  • Pfizer
  • Teva

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Mefenamic Acid Market Size (2021-2032)
  4. 2.2.2 Global Mefenamic Acid Sales (2021-2032)
  5. 2.2.3 Global Mefenamic Acid Market Average Price (2021-2032)
  6. 2.3 Mefenamic Acid by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Patent
  9. 2.3.3 Generic
  10. 2.4 Mefenamic Acid by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 On-line
  13. 2.4.3 Drug Store
  14. 2.4.4 Hospital
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Mefenamic Acid Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Mefenamic Acid Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Mefenamic Acid Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Mefenamic Acid Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Mefenamic Acid Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Mefenamic Acid, Product Type & Application
  8. 3.8 Global Manufacturers of Mefenamic Acid, Established Date
  9. 3.9 Global Mefenamic Acid Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AA Pharma
  2. 4.1.1 AA Pharma Company Information
  3. 4.1.2 AA Pharma Business Overview
  4. 4.1.3 AA Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AA Pharma Mefenamic Acid Product Portfolio
  6. 4.1.5 AA Pharma Recent Developments
  7. 4.2 ABL Lifecare
  8. 4.2.1 ABL Lifecare Company Information
  9. 4.2.2 ABL Lifecare Business Overview
  10. 4.2.3 ABL Lifecare Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 ABL Lifecare Mefenamic Acid Product Portfolio
  12. 4.2.5 ABL Lifecare Recent Developments
  13. 4.3 Adelco
  14. 4.3.1 Adelco Company Information
  15. 4.3.2 Adelco Business Overview
  16. 4.3.3 Adelco Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Adelco Mefenamic Acid Product Portfolio
  18. 4.3.5 Adelco Recent Developments
  19. 4.4 Agron Remedies
  20. 4.4.1 Agron Remedies Company Information
  21. 4.4.2 Agron Remedies Business Overview
  22. 4.4.3 Agron Remedies Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Agron Remedies Mefenamic Acid Product Portfolio
  24. 4.4.5 Agron Remedies Recent Developments
  25. 4.5 Apotex
  26. 4.5.1 Apotex Company Information
  27. 4.5.2 Apotex Business Overview
  28. 4.5.3 Apotex Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Apotex Mefenamic Acid Product Portfolio
  30. 4.5.5 Apotex Recent Developments
  31. 4.6 Captab
  32. 4.6.1 Captab Company Information
  33. 4.6.2 Captab Business Overview
  34. 4.6.3 Captab Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Captab Mefenamic Acid Product Portfolio
  36. 4.6.5 Captab Recent Developments
  37. 4.7 Chemidex Pharma
  38. 4.7.1 Chemidex Pharma Company Information
  39. 4.7.2 Chemidex Pharma Business Overview
  40. 4.7.3 Chemidex Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Chemidex Pharma Mefenamic Acid Product Portfolio
  42. 4.7.5 Chemidex Pharma Recent Developments
  43. 4.8 Daiichi Sankyo
  44. 4.8.1 Daiichi Sankyo Company Information
  45. 4.8.2 Daiichi Sankyo Business Overview
  46. 4.8.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
  48. 4.8.5 Daiichi Sankyo Recent Developments
  49. 4.9 EMS Pharma
  50. 4.9.1 EMS Pharma Company Information
  51. 4.9.2 EMS Pharma Business Overview
  52. 4.9.3 EMS Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 EMS Pharma Mefenamic Acid Product Portfolio
  54. 4.9.5 EMS Pharma Recent Developments
  55. 4.10 Esteve
  56. 4.10.1 Esteve Company Information
  57. 4.10.2 Esteve Business Overview
  58. 4.10.3 Esteve Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Esteve Mefenamic Acid Product Portfolio
  60. 4.10.5 Esteve Recent Developments
  61. 4.11 Farmo Quimica
  62. 4.11.1 Farmo Quimica Company Information
  63. 4.11.2 Farmo Quimica Business Overview
  64. 4.11.3 Farmo Quimica Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Farmo Quimica Mefenamic Acid Product Portfolio
  66. 4.11.5 Farmo Quimica Recent Developments
  67. 4.12 IASIS Pharmaceuticals Hellas
  68. 4.12.1 IASIS Pharmaceuticals Hellas Company Information
  69. 4.12.2 IASIS Pharmaceuticals Hellas Business Overview
  70. 4.12.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
  72. 4.12.5 IASIS Pharmaceuticals Hellas Recent Developments
  73. 4.13 Koa Isei
  74. 4.13.1 Koa Isei Company Information
  75. 4.13.2 Koa Isei Business Overview
  76. 4.13.3 Koa Isei Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Koa Isei Mefenamic Acid Product Portfolio
  78. 4.13.5 Koa Isei Recent Developments
  79. 4.14 Mankind
  80. 4.14.1 Mankind Company Information
  81. 4.14.2 Mankind Business Overview
  82. 4.14.3 Mankind Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Mankind Mefenamic Acid Product Portfolio
  84. 4.14.5 Mankind Recent Developments
  85. 4.15 Nisshin Pharmaceutical
  86. 4.15.1 Nisshin Pharmaceutical Company Information
  87. 4.15.2 Nisshin Pharmaceutical Business Overview
  88. 4.15.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
  90. 4.15.5 Nisshin Pharmaceutical Recent Developments
  91. 4.16 Sanofi Aventis
  92. 4.16.1 Sanofi Aventis Company Information
  93. 4.16.2 Sanofi Aventis Business Overview
  94. 4.16.3 Sanofi Aventis Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sanofi Aventis Mefenamic Acid Product Portfolio
  96. 4.16.5 Sanofi Aventis Recent Developments
  97. 4.17 Shinto Organics
  98. 4.17.1 Shinto Organics Company Information
  99. 4.17.2 Shinto Organics Business Overview
  100. 4.17.3 Shinto Organics Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Shinto Organics Mefenamic Acid Product Portfolio
  102. 4.17.5 Shinto Organics Recent Developments
  103. 4.18 Shionogi Pharma
  104. 4.18.1 Shionogi Pharma Company Information
  105. 4.18.2 Shionogi Pharma Business Overview
  106. 4.18.3 Shionogi Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Shionogi Pharma Mefenamic Acid Product Portfolio
  108. 4.18.5 Shionogi Pharma Recent Developments
  109. 4.19 Solitaire Pharmacia
  110. 4.19.1 Solitaire Pharmacia Company Information
  111. 4.19.2 Solitaire Pharmacia Business Overview
  112. 4.19.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
  114. 4.19.5 Solitaire Pharmacia Recent Developments
  115. 4.20 Streuli Pharma,
  116. 4.20.1 Streuli Pharma, Company Information
  117. 4.20.2 Streuli Pharma, Business Overview
  118. 4.20.3 Streuli Pharma, Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Streuli Pharma, Mefenamic Acid Product Portfolio
  120. 4.20.5 Streuli Pharma, Recent Developments
  121. 4.21 Wockhardt
  122. 4.21.1 Wockhardt Company Information
  123. 4.21.2 Wockhardt Business Overview
  124. 4.21.3 Wockhardt Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Wockhardt Mefenamic Acid Product Portfolio
  126. 4.21.5 Wockhardt Recent Developments
  127. 4.22 Yung Sine
  128. 4.22.1 Yung Sine Company Information
  129. 4.22.2 Yung Sine Business Overview
  130. 4.22.3 Yung Sine Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Yung Sine Mefenamic Acid Product Portfolio
  132. 4.22.5 Yung Sine Recent Developments
  133. 4.23 Pfizer
  134. 4.23.1 Pfizer Company Information
  135. 4.23.2 Pfizer Business Overview
  136. 4.23.3 Pfizer Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Pfizer Mefenamic Acid Product Portfolio
  138. 4.23.5 Pfizer Recent Developments
  139. 4.24 Teva
  140. 4.24.1 Teva Company Information
  141. 4.24.2 Teva Business Overview
  142. 4.24.3 Teva Mefenamic Acid Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Teva Mefenamic Acid Product Portfolio
  144. 4.24.5 Teva Recent Developments
5 Global Mefenamic Acid Market Scenario by Region
  1. 5.1 Global Mefenamic Acid Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Mefenamic Acid Sales by Region: 2021-2032
  3. 5.2.1 Global Mefenamic Acid Sales by Region: 2021-2026
  4. 5.2.2 Global Mefenamic Acid Sales by Region: 2027-2032
  5. 5.3 Global Mefenamic Acid Revenue by Region: 2021-2032
  6. 5.3.1 Global Mefenamic Acid Revenue by Region: 2021-2026
  7. 5.3.2 Global Mefenamic Acid Revenue by Region: 2027-2032
  8. 5.4 North America Mefenamic Acid Market Facts & Figures by Country
  9. 5.4.1 North America Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Mefenamic Acid Sales by Country (2021-2032)
  11. 5.4.3 North America Mefenamic Acid Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Mefenamic Acid Market Facts & Figures by Country
  15. 5.5.1 Europe Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Mefenamic Acid Sales by Country (2021-2032)
  17. 5.5.3 Europe Mefenamic Acid Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Mefenamic Acid Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Mefenamic Acid Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Mefenamic Acid Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Mefenamic Acid Market Facts & Figures by Country
  35. 5.7.1 South America Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Mefenamic Acid Sales by Country (2021-2032)
  37. 5.7.3 South America Mefenamic Acid Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Mefenamic Acid Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Mefenamic Acid Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Mefenamic Acid Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Mefenamic Acid Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Mefenamic Acid Sales by Type (2021-2032)
  2. 6.1.1 Global Mefenamic Acid Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Mefenamic Acid Sales Market Share by Type (2021-2032)
  4. 6.2 Global Mefenamic Acid Revenue by Type (2021-2032)
  5. 6.2.1 Global Mefenamic Acid Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Mefenamic Acid Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Mefenamic Acid Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Mefenamic Acid Sales by Application (2021-2032)
  2. 7.1.1 Global Mefenamic Acid Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Mefenamic Acid Sales Market Share by Application (2021-2032)
  4. 7.2 Global Mefenamic Acid Revenue by Application (2021-2032)
  5. 7.2.1 Global Mefenamic Acid Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Mefenamic Acid Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Mefenamic Acid Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Mefenamic Acid Value Chain Analysis
  2. 8.1.1 Mefenamic Acid Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Mefenamic Acid Production Mode & Process
  5. 8.2 Mefenamic Acid Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Mefenamic Acid Distributors
  8. 8.2.3 Mefenamic Acid Customers
9 Global Mefenamic Acid Analyzing Market Dynamics
  1. 9.1 Mefenamic Acid Industry Trends
  2. 9.2 Mefenamic Acid Industry Drivers
  3. 9.3 Mefenamic Acid Industry Opportunities and Challenges
  4. 9.4 Mefenamic Acid Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst